NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
This grant opportunity invites small businesses to apply for funding to conduct exploratory clinical trials on investigational drugs, biologics, surgical therapies, or devices. These trials should help gather necessary data and justification for designing larger clinical studies. The diseases selected for study should align with the NINDS strategic plan and clinical research focus areas.
Source
Award
Dates
Program & Phase
Keywords
Supporting Links
Documents
Similar Opportunities
-
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
National Institutes of Health
-
DoW Autism Clinical Trial Award
Dept. of the Army -- USAMRAA
-
DoW Vision, Translational Research Award
Dept. of the Army -- USAMRAA
-
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
National Institutes of Health
-
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers